540 related articles for article (PubMed ID: 18962920)
1. Clinical spectrum of diffuse infiltrating retinoblastoma in 34 consecutive eyes.
Shields CL; Ghassemi F; Tuncer S; Thangappan A; Shields JA
Ophthalmology; 2008 Dec; 115(12):2253-8. PubMed ID: 18962920
[TBL] [Abstract][Full Text] [Related]
2. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
4. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
5. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
[TBL] [Abstract][Full Text] [Related]
6. Cavitary changes in retinoblastoma: relationship to chemoresistance.
Mashayekhi A; Shields CL; Eagle RC; Shields JA
Ophthalmology; 2005 Jun; 112(6):1145-50. PubMed ID: 15885779
[TBL] [Abstract][Full Text] [Related]
7. Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retinoblastoma: a prospective study.
Chawla B; Sharma S; Sen S; Azad R; Bajaj MS; Kashyap S; Pushker N; Ghose S
Ophthalmology; 2012 Apr; 119(4):850-6. PubMed ID: 22218144
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
Naseripour M; Nazari H; Bakhtiari P; Modarres-zadeh M; Vosough P; Ausari M
Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
[TBL] [Abstract][Full Text] [Related]
9. Diffuse anterior retinoblastoma without retinal involvement.
Longmuir SQ; Syed NA; Boldt HC
Ophthalmology; 2010 Oct; 117(10):2034-8. PubMed ID: 20663567
[TBL] [Abstract][Full Text] [Related]
10. Multiple anterior and posterior chamber pseudocysts in a 12-year-old boy with diffuse infiltrating retinoblastoma.
Tuncer S; Peksayar G; Kebudi R; Tugal-Tutkun I; Buyukbabani N; Darendeliler E
J Pediatr Ophthalmol Strabismus; 2009; 46(5):312-6. PubMed ID: 19791731
[TBL] [Abstract][Full Text] [Related]
11. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis of retinoblastoma. Report of 50 cases].
Bouguila H; Malek I; Boujemâa C; Mouelhi M; Daghfous F; Nacef L; Ayed S
J Fr Ophtalmol; 2001 Dec; 24(10):1053-6. PubMed ID: 11913235
[TBL] [Abstract][Full Text] [Related]
13. Glaucoma in retinoblastoma.
de Leon JM; Walton DS; Latina MA; Mercado GV
Semin Ophthalmol; 2005; 20(4):217-22. PubMed ID: 16352492
[TBL] [Abstract][Full Text] [Related]
14. Diffuse infiltrating retinoblastoma presenting as a spontaneous hyphema.
Shields JA; Shields CL; Materin M
J Pediatr Ophthalmol Strabismus; 2000; 37(5):311-2. PubMed ID: 11020116
[No Abstract] [Full Text] [Related]
15. Vitrectomy in eyes with unsuspected retinoblastoma.
Shields CL; Honavar S; Shields JA; Demirci H; Meadows AT
Ophthalmology; 2000 Dec; 107(12):2250-5. PubMed ID: 11097606
[TBL] [Abstract][Full Text] [Related]
16. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
[TBL] [Abstract][Full Text] [Related]
17. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors of high risk histopathology in retinoblastoma.
Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
[TBL] [Abstract][Full Text] [Related]
19. Intracorneal ring segment implantation in corneas with post-laser in situ keratomileusis keratectasia.
Piñero DP; Alio JL; Uceda-Montanes A; El Kady B; Pascual I
Ophthalmology; 2009 Sep; 116(9):1665-74. PubMed ID: 19643485
[TBL] [Abstract][Full Text] [Related]
20. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
Kaliki S; Shields CL; Rojanaporn D; Al-Dahmash S; McLaughlin JP; Shields JA; Eagle RC
Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
